Association between microscopic hematuria and albuminuria in patients with chronic kidney disease caused by diabetes and hypertension: the Fukuoka Kidney disease Registry Study

被引:1
|
作者
Nakagawa, Kaneyasu [1 ,2 ,3 ]
Tanaka, Shigeru [1 ]
Tsuruya, Kazuhiko [4 ]
Kitazono, Takanari [1 ]
Nakano, Toshiaki [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, 3-1-1 Maidashi, Higashi, Fukuoka 8128582, Japan
[2] Japanese Red Cross Fukuoka Hosp, Div Nephrol, Fukuoka, Japan
[3] Japanese Red Cross Fukuoka Hosp, Dialysis Ctr, Fukuoka, Japan
[4] Nara Med Univ, Dept Nephrol, Kashihara, Nara, Japan
关键词
Albuminuria; Microscopic hematuria; Chronic kidney disease; Diabetic nephropathy and hypertensive nephrosclerosis; GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; IGA NEPHROPATHY; RISK-FACTOR; PROTEINURIA; PROGRESSION; INJURY; DEFINITION; MORTALITY; EXCRETION;
D O I
10.1007/s10157-022-02298-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background The association between microscopic hematuria (MH) and albuminuria in patients with chronic kidney disease (CKD) caused by diabetes and hypertension remains unclear. Methods The Fukuoka Kidney disease Registry Study is a Japanese multicenter prospective cohort study of 4476 patients with non-dialysis-dependent CKD. In this cohort, we conducted a cross-sectional study in 994 patients with diabetic nephropathy and hypertensive nephrosclerosis. Patients were divided into three groups according to erythrocyte count in urine sediment [T1: < 5/high power field (HPF); T2: 5-9/HPF; T3: >= 10/HPF]. Macroalbuminuria was defined as urinary albumin-creatinine ratio > 300 mg/g. Associations between the degree of MH (T1-T3) and the prevalence of macroalbuminuria were analyzed using logistic regression. Results The prevalence of macroalbuminuria was 50.8%, 50.4%, and 67.4% in T1 (n = 725), T2 (n = 226), and T3 (n = 43), respectively. The multivariable-adjusted odds ratios for the presence of macroalbuminuria were 0.95 [95% confidence interval (CI) 0.65-1.39; P = 0.86] and 2.50 (95% CI 1.15-5.47; P = 0.022) for patients in T2 and T3, respectively, compared with patients in T1. Conclusions MH with erythrocytes >= 10/HPF was significantly associated with increased prevalence of macroalbuminuria in patients with non-dialysis-dependent CKD caused by diabetes and hypertension.
引用
收藏
页码:227 / 235
页数:9
相关论文
共 50 条
  • [1] Association between microscopic hematuria and albuminuria in patients with chronic kidney disease caused by diabetes and hypertension: the Fukuoka Kidney disease Registry Study
    Kaneyasu Nakagawa
    Shigeru Tanaka
    Kazuhiko Tsuruya
    Takanari Kitazono
    Toshiaki Nakano
    Clinical and Experimental Nephrology, 2023, 27 : 227 - 235
  • [2] Association between urinary salt excretion and albuminuria in Japanese patients with chronic kidney disease: the Fukuoka kidney disease registry study
    Fukui, Akiko
    Nakayama, Masaru
    Tanaka, Shigeru
    Matsukuma, Yuta
    Yoshitomi, Ryota
    Nakano, Toshiaki
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (01) : 9 - 18
  • [3] Association between urinary salt excretion and albuminuria in Japanese patients with chronic kidney disease: the Fukuoka kidney disease registry study
    Akiko Fukui
    Masaru Nakayama
    Shigeru Tanaka
    Yuta Matsukuma
    Ryota Yoshitomi
    Toshiaki Nakano
    Kazuhiko Tsuruya
    Takanari Kitazono
    Clinical and Experimental Nephrology, 2021, 25 : 9 - 18
  • [4] Associations between the Serum Triglyceride Level and Kidney Outcome in Patients with Chronic Kidney Disease: The Fukuoka Kidney disease Registry Study
    Seki, Mai
    Nakano, Toshiaki
    Tanaka, Shigeru
    Kitamura, Hiromasa
    Hiyamuta, Hiroto
    Ninomiya, Toshiharu
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (11) : 1556 - 1570
  • [5] Prevalence of hyponatremia and associated factors in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry (FKR) study
    Inoue, Megumi
    Nakai, Kentaro
    Tanaka, Shigeru
    Mitsuiki, Koji
    Tokumoto, Masanori
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    Nakano, Toshiaki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2023, 27 (12) : 1023 - 1031
  • [6] Prevalence of hyponatremia and associated factors in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry (FKR) study
    Megumi Inoue
    Kentaro Nakai
    Shigeru Tanaka
    Koji Mitsuiki
    Masanori Tokumoto
    Kazuhiko Tsuruya
    Takanari Kitazono
    Toshiaki Nakano
    Clinical and Experimental Nephrology, 2023, 27 : 1023 - 1031
  • [7] Association between bilirubin and chronic kidney disease in hypertensive patients: The China hypertension registry study
    Zhao, Peixu
    Xu, Haitao
    Shi, Yumeng
    Song, Xiaoli
    Qiu, Guosheng
    Ding, Congcong
    Zhou, Wei
    Yu, Chao
    Wang, Tao
    Zhu, Lingjuan
    Bao, Huihui
    Cheng, Xiaoshu
    JOURNAL OF CLINICAL HYPERTENSION, 2023, 25 (12): : 1185 - 1192
  • [8] Association between prevalence of laxative use and history of bone fractures and cardiovascular diseases in patients with chronic kidney disease: the Fukuoka Kidney disease Registry (FKR) study
    Shunsuke Yamada
    Shigeru Tanaka
    Hokuto Arase
    Hiroto Hiyamuta
    Hiromasa Kitamura
    Masanori Tokumoto
    Koji Mitsuiki
    Kazuhiko Tsuruya
    Takanari Kitazono
    Toshiaki Nakano
    Clinical and Experimental Nephrology, 2023, 27 : 151 - 160
  • [9] Association Between Plasma Intact Parathyroid Hormone Levels and the Prevalence of Atrial Fibrillation in Patients With Chronic Kidney Disease -The Fukuoka Kidney Disease Registry Study-
    Arase, Hokuto
    Yamada, Shunsuke
    Tanaka, Shigeru
    Tokumoto, Masanori
    Tsuruya, Kazuhiko
    Nakano, Toshiaki
    Kitazono, Takanari
    CIRCULATION JOURNAL, 2020, 84 (07) : 1105 - +
  • [10] Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study
    Nakano, Toshiaki
    Tanaka, Shigeru
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (04) : 385 - 393